URDANETA CITY UNIVERSITY

San Vicente West, Urdaneta City, Philippines-2428

Telefax No.: 075-568-7612
Email Address: info@ucu.edu.ph

PHARMACOLOGY
POST QUIZ INTRO TO DRUGS
NAME ____________________________________
Date _______________________________

SCORE ____________
RATING ___________

PART I IDENTIFICATION Write the correct term on the space provided. NO ERASURES
IN ALL TEST.
1.
2.
3.
4.

_______________________ The study of the biologic effects of a chemical

_______________________ The trade name of a drug
_______________________ The designation for a drug that reflects chemical structure
_______________________ The original drug designation given when the drug company
applies for approval
5. _______________________ Undesirable of possible dangerous result of a drug
6. _______________________ Drugs available without a prescription
7. _______________________ Drugs that have been discovered but that are not financially
viable
8. _______________________ Chemicals that are introduced into the body to bring about
some sort of change
9. _______________________ An agency responsible for the regulation and enforcement of
drug evaluation and distribution policies in the Philippines
10. _______________________ One source of drugs

PART II MULTIPLE- CHOICE Read the following questions carefully. Encircle the letter of
the correct answer.
1. During a phase II study a drug may be removed from testing for which reason?
a. Greater than anticipated effectiveness
b. Low risk for toxicity
c. High benefit-to-risk ration
d. Unacceptable adverse effects
2. During which stage of drug development is the drug tests on laboratory animals?
a. Preclinical trial
b. Phase I study

c. Phase II study
d. Phase III study

3. Which phase of drug development is associated with continual evaluation of the

drug?
a. Phase I study
b. Phase II study
c. Phase III study

d. Phase IV study
4.
5.
6. Male volunteers are usually selected for drug testing during a phase study for which
reason?
a. Women are more unreliable in terms adhering to the terms of the study
b. Men are typically have a greater consistency in body-build and make-up
c. The risk of damaging or destroying ova is too great
d. Men are less likely to develop toxic effects related to the drug
7. A nurse is administering a drug to a patient who had the disease for which a drug is
designed to treat. The nurse is most likely participating in which of the following?
a. Preclinical trial
b. Phase I study

c. Phase II study
d. Phase III study

e.
f.

PART II SEQUENCING - Place the number of the statement that reflects a

step in the process of drug evaluation.

g. _____ Healthy male volunteers are used to test the drugs.

h. _____ The Food and Drug Administration (FDA) approved the drug.
i.

_____ Patients with the disease receive the drug.

j.

_____ The drug is tested in the laboratory using animals.

k. _____ Prescribers administer the drug reporting any unexpected adverse

effects.
l.

PART III FILL IN THE BLANKS Provide the missing term or terms in the
blanks provided.

1. In taking clients history the nurse should ask ______________ questions phrased in
language appropriate to the clients educational level.
2. In questioning clients, the nurse should be aware that they may misidentify an
_____________ effects as an allergic response.
3. In diagnosing noncompliance the nurse should always attempt to identify the
_______________ such as financial resources or knowledge deficits or
misunderstanding.
4. It is important to determine whether the client has _______________ abilities which can
be negatively affected by disease or medication to comply with therapeutic regimen.
5. Asking clients about their socioeconomic status and educational level and beliefs will
help identify _______________ problems with compliance and important knowledge
deficits.
m. Doing whats right today means no regrets tomorrow
n. Prepared by:
o. ANNALISA A. TELLES, RN-MAN
p. Instructor, Clinical Coordinator
q.
r.
s.
t.
1.
2.
3.
4.
5.
6.

Key answer

Pharmacology
Brand name
Generic name
Chemical name
Adverse effects
Otc

7. Orphan
8. Drug
9. Bfad
10. Plant
u. Mc
1.
2.
3.
4.
5.

D
A
D
D
B
v. Sequencing
w. 1 2
x. 2 5
y.

33

z. 4 1
aa. 5 4
ab. Fill in the blanks
1.
2.
3.
4.
5.

Open ended
Adverse
cause
Coginitive
Potential
ac.

ad.